COGNITION THERAPEUTICS INC (CGTX) Insider Trading
Sector: Pharmaceuticals · Market Cap: $121M · 0 insider purchases in the last 7 days
No open market insider purchases at COGNITION THERAPEUTICS INC in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track CGTX on your watchlist.
Start for FreeAbout COGNITION THERAPEUTICS INC Insider Trading
3 insiders at COGNITION THERAPEUTICS INC (CGTX) have purchased stock in the past 90 days, totaling $32K across 3 transactions (29,175 shares).
The most recent purchase was by CEO Ricciardi Lisa on April 16, 2026 — a $10K buy of 9,175 shares at $1.10, bringing his total holdings to 1,715,851 shares.
Insiders who purchased: Doyle John Brendan (CFO, 1 buy totaling $11K); Caggiano Anthony (Chief Medical Officer, 1 buy totaling $11K); Ricciardi Lisa (CEO, 1 buy totaling $10K).
This insider buying is notable given that CGTX had no recorded open market purchases in the nine months before that.
CGTX is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $121M.
With 3 different insiders buying in the same 90-day window, this qualifies as cluster buying at CGTX — a pattern that research suggests can signal conviction among management.
Track CGTX insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.